Enzo Biochem (NYSE: ENZ) is an integrated life science and biotechnology company engaged in the R&D, manufacture and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, which provides routine and esoteric clinical laboratory tests or procedures used in general patient care to establish or support a diagnosis; Life Sciences, which manufactures, develops, and markets products and tools to life sciences, drug development, and clinical research customers; and Therapeutics, which is involved in the research and development of therapeutic drug candidates in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases. For more information, visit the company’s website at www.enzo.com.
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.networknewswire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
